Global Nifedipine Extended Release Tablets Market Growth 2026-2032
The global Nifedipine Extended Release Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
By inhibiting the calcium channel on the cell membrane, slowing down the inflow of calcium ions, reducing the contractility of the heart and the oxygen consumption of the heart, thereby dilating the coronary arteries, increasing the blood supply to the heart, lowering blood pressure, improving the blood supply to the heart and reducing the burden on the heart. Because it is a sustained-release tablet, the drug is released at a controlled rate, allowing its effects to last for a period of time.
United States market for Nifedipine Extended Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Nifedipine Extended Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Nifedipine Extended Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Nifedipine Extended Release Tablets players cover Valeant Pharmaceuticals, Zydus Pharmaceuticals Inc, Aurobindo Pharma LTD, Pfizer Inc, Sun Pharma Industries LTD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Nifedipine Extended Release Tablets Industry Forecast? looks at past sales and reviews total world Nifedipine Extended Release Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Nifedipine Extended Release Tablets sales for 2026 through 2032. With Nifedipine Extended Release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nifedipine Extended Release Tablets industry.
This Insight Report provides a comprehensive analysis of the global Nifedipine Extended Release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nifedipine Extended Release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Nifedipine Extended Release Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nifedipine Extended Release Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nifedipine Extended Release Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Nifedipine Extended Release Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
By inhibiting the calcium channel on the cell membrane, slowing down the inflow of calcium ions, reducing the contractility of the heart and the oxygen consumption of the heart, thereby dilating the coronary arteries, increasing the blood supply to the heart, lowering blood pressure, improving the blood supply to the heart and reducing the burden on the heart. Because it is a sustained-release tablet, the drug is released at a controlled rate, allowing its effects to last for a period of time.
United States market for Nifedipine Extended Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Nifedipine Extended Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Nifedipine Extended Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Nifedipine Extended Release Tablets players cover Valeant Pharmaceuticals, Zydus Pharmaceuticals Inc, Aurobindo Pharma LTD, Pfizer Inc, Sun Pharma Industries LTD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Nifedipine Extended Release Tablets Industry Forecast? looks at past sales and reviews total world Nifedipine Extended Release Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Nifedipine Extended Release Tablets sales for 2026 through 2032. With Nifedipine Extended Release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nifedipine Extended Release Tablets industry.
This Insight Report provides a comprehensive analysis of the global Nifedipine Extended Release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nifedipine Extended Release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Nifedipine Extended Release Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nifedipine Extended Release Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nifedipine Extended Release Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Nifedipine Extended Release Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Original Drug
- Generic Drug
- Hospital
- Pharmacy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Valeant Pharmaceuticals
- Zydus Pharmaceuticals Inc
- Aurobindo Pharma LTD
- Pfizer Inc
- Sun Pharma Industries LTD
- Osmotica Pharmaceuticals
- Alkem Laboratories Ltd.
- Novast Novast Laboratories, LTD
- TWi Pharmaceuticals Inc.
- Shyndec Pharmaceutical Co., Ltd
- China National Pharmaceutical Industry Co., Ltd
- China Resource Pharmaceutical Group Co., Ltd
- Anglikang Pharmaceutical Co., Ltd
- Warrant Chiral Pharmaceutical Co., Ltd
- Tailison Pharmaceutical Co., Ltd
- Baheal Medical Inc.
- Bocheng Pharmaceutical Co., Ltd
- What is the 10-year outlook for the global Nifedipine Extended Release Tablets market?
- What factors are driving Nifedipine Extended Release Tablets market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Nifedipine Extended Release Tablets market opportunities vary by end market size?
- How does Nifedipine Extended Release Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nifedipine Extended Release Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nifedipine Extended Release Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nifedipine Extended Release Tablets by Country/Region, 2021, 2025 & 2032
2.2 Nifedipine Extended Release Tablets Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.2.3 Nifedipine Extended Release Tablets Sales by Type
2.2.3.1 Global Nifedipine Extended Release Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Nifedipine Extended Release Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Nifedipine Extended Release Tablets Sale Price by Type (2021-2026)
2.3 Nifedipine Extended Release Tablets Segment by Application
2.3.1 Hospital
2.3.2 Pharmacy
2.3.3 Others
2.3.4 Nifedipine Extended Release Tablets Sales by Application
2.3.4.1 Global Nifedipine Extended Release Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Nifedipine Extended Release Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Nifedipine Extended Release Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nifedipine Extended Release Tablets Breakdown Data by Company
3.1.1 Global Nifedipine Extended Release Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Nifedipine Extended Release Tablets Sales Market Share by Company (2021-2026)
3.2 Global Nifedipine Extended Release Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Nifedipine Extended Release Tablets Revenue by Company (2021-2026)
3.2.2 Global Nifedipine Extended Release Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Nifedipine Extended Release Tablets Sale Price by Company
3.4 Key Manufacturers Nifedipine Extended Release Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nifedipine Extended Release Tablets Product Location Distribution
3.4.2 Players Nifedipine Extended Release Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NIFEDIPINE EXTENDED RELEASE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Nifedipine Extended Release Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Nifedipine Extended Release Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nifedipine Extended Release Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nifedipine Extended Release Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Nifedipine Extended Release Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nifedipine Extended Release Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nifedipine Extended Release Tablets Sales Growth
4.4 APAC Nifedipine Extended Release Tablets Sales Growth
4.5 Europe Nifedipine Extended Release Tablets Sales Growth
4.6 Middle East & Africa Nifedipine Extended Release Tablets Sales Growth
5 AMERICAS
5.1 Americas Nifedipine Extended Release Tablets Sales by Country
5.1.1 Americas Nifedipine Extended Release Tablets Sales by Country (2021-2026)
5.1.2 Americas Nifedipine Extended Release Tablets Revenue by Country (2021-2026)
5.2 Americas Nifedipine Extended Release Tablets Sales by Type (2021-2026)
5.3 Americas Nifedipine Extended Release Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nifedipine Extended Release Tablets Sales by Region
6.1.1 APAC Nifedipine Extended Release Tablets Sales by Region (2021-2026)
6.1.2 APAC Nifedipine Extended Release Tablets Revenue by Region (2021-2026)
6.2 APAC Nifedipine Extended Release Tablets Sales by Type (2021-2026)
6.3 APAC Nifedipine Extended Release Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nifedipine Extended Release Tablets by Country
7.1.1 Europe Nifedipine Extended Release Tablets Sales by Country (2021-2026)
7.1.2 Europe Nifedipine Extended Release Tablets Revenue by Country (2021-2026)
7.2 Europe Nifedipine Extended Release Tablets Sales by Type (2021-2026)
7.3 Europe Nifedipine Extended Release Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nifedipine Extended Release Tablets by Country
8.1.1 Middle East & Africa Nifedipine Extended Release Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nifedipine Extended Release Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Nifedipine Extended Release Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Nifedipine Extended Release Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nifedipine Extended Release Tablets
10.3 Manufacturing Process Analysis of Nifedipine Extended Release Tablets
10.4 Industry Chain Structure of Nifedipine Extended Release Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nifedipine Extended Release Tablets Distributors
11.3 Nifedipine Extended Release Tablets Customer
12 WORLD FORECAST REVIEW FOR NIFEDIPINE EXTENDED RELEASE TABLETS BY GEOGRAPHIC REGION
12.1 Global Nifedipine Extended Release Tablets Market Size Forecast by Region
12.1.1 Global Nifedipine Extended Release Tablets Forecast by Region (2027-2032)
12.1.2 Global Nifedipine Extended Release Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nifedipine Extended Release Tablets Forecast by Type (2027-2032)
12.7 Global Nifedipine Extended Release Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Valeant Pharmaceuticals
13.1.1 Valeant Pharmaceuticals Company Information
13.1.2 Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.1.3 Valeant Pharmaceuticals Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Valeant Pharmaceuticals Main Business Overview
13.1.5 Valeant Pharmaceuticals Latest Developments
13.2 Zydus Pharmaceuticals Inc
13.2.1 Zydus Pharmaceuticals Inc Company Information
13.2.2 Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.2.3 Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Zydus Pharmaceuticals Inc Main Business Overview
13.2.5 Zydus Pharmaceuticals Inc Latest Developments
13.3 Aurobindo Pharma LTD
13.3.1 Aurobindo Pharma LTD Company Information
13.3.2 Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.3.3 Aurobindo Pharma LTD Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Aurobindo Pharma LTD Main Business Overview
13.3.5 Aurobindo Pharma LTD Latest Developments
13.4 Pfizer Inc
13.4.1 Pfizer Inc Company Information
13.4.2 Pfizer Inc Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.4.3 Pfizer Inc Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pfizer Inc Main Business Overview
13.4.5 Pfizer Inc Latest Developments
13.5 Sun Pharma Industries LTD
13.5.1 Sun Pharma Industries LTD Company Information
13.5.2 Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.5.3 Sun Pharma Industries LTD Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sun Pharma Industries LTD Main Business Overview
13.5.5 Sun Pharma Industries LTD Latest Developments
13.6 Osmotica Pharmaceuticals
13.6.1 Osmotica Pharmaceuticals Company Information
13.6.2 Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.6.3 Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Osmotica Pharmaceuticals Main Business Overview
13.6.5 Osmotica Pharmaceuticals Latest Developments
13.7 Alkem Laboratories Ltd.
13.7.1 Alkem Laboratories Ltd. Company Information
13.7.2 Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.7.3 Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Alkem Laboratories Ltd. Main Business Overview
13.7.5 Alkem Laboratories Ltd. Latest Developments
13.8 Novast Novast Laboratories, LTD
13.8.1 Novast Novast Laboratories, LTD Company Information
13.8.2 Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.8.3 Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Novast Novast Laboratories, LTD Main Business Overview
13.8.5 Novast Novast Laboratories, LTD Latest Developments
13.9 TWi Pharmaceuticals Inc.
13.9.1 TWi Pharmaceuticals Inc. Company Information
13.9.2 TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.9.3 TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 TWi Pharmaceuticals Inc. Main Business Overview
13.9.5 TWi Pharmaceuticals Inc. Latest Developments
13.10 Shyndec Pharmaceutical Co., Ltd
13.10.1 Shyndec Pharmaceutical Co., Ltd Company Information
13.10.2 Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.10.3 Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Shyndec Pharmaceutical Co., Ltd Main Business Overview
13.10.5 Shyndec Pharmaceutical Co., Ltd Latest Developments
13.11 China National Pharmaceutical Industry Co., Ltd
13.11.1 China National Pharmaceutical Industry Co., Ltd Company Information
13.11.2 China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.11.3 China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 China National Pharmaceutical Industry Co., Ltd Main Business Overview
13.11.5 China National Pharmaceutical Industry Co., Ltd Latest Developments
13.12 China Resource Pharmaceutical Group Co., Ltd
13.12.1 China Resource Pharmaceutical Group Co., Ltd Company Information
13.12.2 China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.12.3 China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 China Resource Pharmaceutical Group Co., Ltd Main Business Overview
13.12.5 China Resource Pharmaceutical Group Co., Ltd Latest Developments
13.13 Anglikang Pharmaceutical Co., Ltd
13.13.1 Anglikang Pharmaceutical Co., Ltd Company Information
13.13.2 Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.13.3 Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Anglikang Pharmaceutical Co., Ltd Main Business Overview
13.13.5 Anglikang Pharmaceutical Co., Ltd Latest Developments
13.14 Warrant Chiral Pharmaceutical Co., Ltd
13.14.1 Warrant Chiral Pharmaceutical Co., Ltd Company Information
13.14.2 Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.14.3 Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Warrant Chiral Pharmaceutical Co., Ltd Main Business Overview
13.14.5 Warrant Chiral Pharmaceutical Co., Ltd Latest Developments
13.15 Tailison Pharmaceutical Co., Ltd
13.15.1 Tailison Pharmaceutical Co., Ltd Company Information
13.15.2 Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.15.3 Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Tailison Pharmaceutical Co., Ltd Main Business Overview
13.15.5 Tailison Pharmaceutical Co., Ltd Latest Developments
13.16 Baheal Medical Inc.
13.16.1 Baheal Medical Inc. Company Information
13.16.2 Baheal Medical Inc. Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.16.3 Baheal Medical Inc. Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Baheal Medical Inc. Main Business Overview
13.16.5 Baheal Medical Inc. Latest Developments
13.17 Bocheng Pharmaceutical Co., Ltd
13.17.1 Bocheng Pharmaceutical Co., Ltd Company Information
13.17.2 Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.17.3 Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Bocheng Pharmaceutical Co., Ltd Main Business Overview
13.17.5 Bocheng Pharmaceutical Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nifedipine Extended Release Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nifedipine Extended Release Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nifedipine Extended Release Tablets by Country/Region, 2021, 2025 & 2032
2.2 Nifedipine Extended Release Tablets Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.2.3 Nifedipine Extended Release Tablets Sales by Type
2.2.3.1 Global Nifedipine Extended Release Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Nifedipine Extended Release Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Nifedipine Extended Release Tablets Sale Price by Type (2021-2026)
2.3 Nifedipine Extended Release Tablets Segment by Application
2.3.1 Hospital
2.3.2 Pharmacy
2.3.3 Others
2.3.4 Nifedipine Extended Release Tablets Sales by Application
2.3.4.1 Global Nifedipine Extended Release Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Nifedipine Extended Release Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Nifedipine Extended Release Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nifedipine Extended Release Tablets Breakdown Data by Company
3.1.1 Global Nifedipine Extended Release Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Nifedipine Extended Release Tablets Sales Market Share by Company (2021-2026)
3.2 Global Nifedipine Extended Release Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Nifedipine Extended Release Tablets Revenue by Company (2021-2026)
3.2.2 Global Nifedipine Extended Release Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Nifedipine Extended Release Tablets Sale Price by Company
3.4 Key Manufacturers Nifedipine Extended Release Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nifedipine Extended Release Tablets Product Location Distribution
3.4.2 Players Nifedipine Extended Release Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NIFEDIPINE EXTENDED RELEASE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Nifedipine Extended Release Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Nifedipine Extended Release Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nifedipine Extended Release Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nifedipine Extended Release Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Nifedipine Extended Release Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nifedipine Extended Release Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nifedipine Extended Release Tablets Sales Growth
4.4 APAC Nifedipine Extended Release Tablets Sales Growth
4.5 Europe Nifedipine Extended Release Tablets Sales Growth
4.6 Middle East & Africa Nifedipine Extended Release Tablets Sales Growth
5 AMERICAS
5.1 Americas Nifedipine Extended Release Tablets Sales by Country
5.1.1 Americas Nifedipine Extended Release Tablets Sales by Country (2021-2026)
5.1.2 Americas Nifedipine Extended Release Tablets Revenue by Country (2021-2026)
5.2 Americas Nifedipine Extended Release Tablets Sales by Type (2021-2026)
5.3 Americas Nifedipine Extended Release Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nifedipine Extended Release Tablets Sales by Region
6.1.1 APAC Nifedipine Extended Release Tablets Sales by Region (2021-2026)
6.1.2 APAC Nifedipine Extended Release Tablets Revenue by Region (2021-2026)
6.2 APAC Nifedipine Extended Release Tablets Sales by Type (2021-2026)
6.3 APAC Nifedipine Extended Release Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nifedipine Extended Release Tablets by Country
7.1.1 Europe Nifedipine Extended Release Tablets Sales by Country (2021-2026)
7.1.2 Europe Nifedipine Extended Release Tablets Revenue by Country (2021-2026)
7.2 Europe Nifedipine Extended Release Tablets Sales by Type (2021-2026)
7.3 Europe Nifedipine Extended Release Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nifedipine Extended Release Tablets by Country
8.1.1 Middle East & Africa Nifedipine Extended Release Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nifedipine Extended Release Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Nifedipine Extended Release Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Nifedipine Extended Release Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nifedipine Extended Release Tablets
10.3 Manufacturing Process Analysis of Nifedipine Extended Release Tablets
10.4 Industry Chain Structure of Nifedipine Extended Release Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nifedipine Extended Release Tablets Distributors
11.3 Nifedipine Extended Release Tablets Customer
12 WORLD FORECAST REVIEW FOR NIFEDIPINE EXTENDED RELEASE TABLETS BY GEOGRAPHIC REGION
12.1 Global Nifedipine Extended Release Tablets Market Size Forecast by Region
12.1.1 Global Nifedipine Extended Release Tablets Forecast by Region (2027-2032)
12.1.2 Global Nifedipine Extended Release Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nifedipine Extended Release Tablets Forecast by Type (2027-2032)
12.7 Global Nifedipine Extended Release Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Valeant Pharmaceuticals
13.1.1 Valeant Pharmaceuticals Company Information
13.1.2 Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.1.3 Valeant Pharmaceuticals Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Valeant Pharmaceuticals Main Business Overview
13.1.5 Valeant Pharmaceuticals Latest Developments
13.2 Zydus Pharmaceuticals Inc
13.2.1 Zydus Pharmaceuticals Inc Company Information
13.2.2 Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.2.3 Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Zydus Pharmaceuticals Inc Main Business Overview
13.2.5 Zydus Pharmaceuticals Inc Latest Developments
13.3 Aurobindo Pharma LTD
13.3.1 Aurobindo Pharma LTD Company Information
13.3.2 Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.3.3 Aurobindo Pharma LTD Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Aurobindo Pharma LTD Main Business Overview
13.3.5 Aurobindo Pharma LTD Latest Developments
13.4 Pfizer Inc
13.4.1 Pfizer Inc Company Information
13.4.2 Pfizer Inc Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.4.3 Pfizer Inc Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pfizer Inc Main Business Overview
13.4.5 Pfizer Inc Latest Developments
13.5 Sun Pharma Industries LTD
13.5.1 Sun Pharma Industries LTD Company Information
13.5.2 Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.5.3 Sun Pharma Industries LTD Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sun Pharma Industries LTD Main Business Overview
13.5.5 Sun Pharma Industries LTD Latest Developments
13.6 Osmotica Pharmaceuticals
13.6.1 Osmotica Pharmaceuticals Company Information
13.6.2 Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.6.3 Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Osmotica Pharmaceuticals Main Business Overview
13.6.5 Osmotica Pharmaceuticals Latest Developments
13.7 Alkem Laboratories Ltd.
13.7.1 Alkem Laboratories Ltd. Company Information
13.7.2 Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.7.3 Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Alkem Laboratories Ltd. Main Business Overview
13.7.5 Alkem Laboratories Ltd. Latest Developments
13.8 Novast Novast Laboratories, LTD
13.8.1 Novast Novast Laboratories, LTD Company Information
13.8.2 Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.8.3 Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Novast Novast Laboratories, LTD Main Business Overview
13.8.5 Novast Novast Laboratories, LTD Latest Developments
13.9 TWi Pharmaceuticals Inc.
13.9.1 TWi Pharmaceuticals Inc. Company Information
13.9.2 TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.9.3 TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 TWi Pharmaceuticals Inc. Main Business Overview
13.9.5 TWi Pharmaceuticals Inc. Latest Developments
13.10 Shyndec Pharmaceutical Co., Ltd
13.10.1 Shyndec Pharmaceutical Co., Ltd Company Information
13.10.2 Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.10.3 Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Shyndec Pharmaceutical Co., Ltd Main Business Overview
13.10.5 Shyndec Pharmaceutical Co., Ltd Latest Developments
13.11 China National Pharmaceutical Industry Co., Ltd
13.11.1 China National Pharmaceutical Industry Co., Ltd Company Information
13.11.2 China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.11.3 China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 China National Pharmaceutical Industry Co., Ltd Main Business Overview
13.11.5 China National Pharmaceutical Industry Co., Ltd Latest Developments
13.12 China Resource Pharmaceutical Group Co., Ltd
13.12.1 China Resource Pharmaceutical Group Co., Ltd Company Information
13.12.2 China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.12.3 China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 China Resource Pharmaceutical Group Co., Ltd Main Business Overview
13.12.5 China Resource Pharmaceutical Group Co., Ltd Latest Developments
13.13 Anglikang Pharmaceutical Co., Ltd
13.13.1 Anglikang Pharmaceutical Co., Ltd Company Information
13.13.2 Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.13.3 Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Anglikang Pharmaceutical Co., Ltd Main Business Overview
13.13.5 Anglikang Pharmaceutical Co., Ltd Latest Developments
13.14 Warrant Chiral Pharmaceutical Co., Ltd
13.14.1 Warrant Chiral Pharmaceutical Co., Ltd Company Information
13.14.2 Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.14.3 Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Warrant Chiral Pharmaceutical Co., Ltd Main Business Overview
13.14.5 Warrant Chiral Pharmaceutical Co., Ltd Latest Developments
13.15 Tailison Pharmaceutical Co., Ltd
13.15.1 Tailison Pharmaceutical Co., Ltd Company Information
13.15.2 Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.15.3 Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Tailison Pharmaceutical Co., Ltd Main Business Overview
13.15.5 Tailison Pharmaceutical Co., Ltd Latest Developments
13.16 Baheal Medical Inc.
13.16.1 Baheal Medical Inc. Company Information
13.16.2 Baheal Medical Inc. Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.16.3 Baheal Medical Inc. Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Baheal Medical Inc. Main Business Overview
13.16.5 Baheal Medical Inc. Latest Developments
13.17 Bocheng Pharmaceutical Co., Ltd
13.17.1 Bocheng Pharmaceutical Co., Ltd Company Information
13.17.2 Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
13.17.3 Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Bocheng Pharmaceutical Co., Ltd Main Business Overview
13.17.5 Bocheng Pharmaceutical Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nifedipine Extended Release Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nifedipine Extended Release Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. Global Nifedipine Extended Release Tablets Sales by Type (2021-2026) & (K Units)
Table 6. Global Nifedipine Extended Release Tablets Sales Market Share by Type (2021-2026)
Table 7. Global Nifedipine Extended Release Tablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Nifedipine Extended Release Tablets Revenue Market Share by Type (2021-2026)
Table 9. Global Nifedipine Extended Release Tablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Nifedipine Extended Release Tablets Sale by Application (2021-2026) & (K Units)
Table 11. Global Nifedipine Extended Release Tablets Sale Market Share by Application (2021-2026)
Table 12. Global Nifedipine Extended Release Tablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global Nifedipine Extended Release Tablets Revenue Market Share by Application (2021-2026)
Table 14. Global Nifedipine Extended Release Tablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Nifedipine Extended Release Tablets Sales by Company (2021-2026) & (K Units)
Table 16. Global Nifedipine Extended Release Tablets Sales Market Share by Company (2021-2026)
Table 17. Global Nifedipine Extended Release Tablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Nifedipine Extended Release Tablets Revenue Market Share by Company (2021-2026)
Table 19. Global Nifedipine Extended Release Tablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Nifedipine Extended Release Tablets Producing Area Distribution and Sales Area
Table 21. Players Nifedipine Extended Release Tablets Products Offered
Table 22. Nifedipine Extended Release Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Nifedipine Extended Release Tablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Nifedipine Extended Release Tablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global Nifedipine Extended Release Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Nifedipine Extended Release Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Nifedipine Extended Release Tablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Nifedipine Extended Release Tablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global Nifedipine Extended Release Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Nifedipine Extended Release Tablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Nifedipine Extended Release Tablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas Nifedipine Extended Release Tablets Sales Market Share by Country (2021-2026)
Table 35. Americas Nifedipine Extended Release Tablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Nifedipine Extended Release Tablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas Nifedipine Extended Release Tablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC Nifedipine Extended Release Tablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC Nifedipine Extended Release Tablets Sales Market Share by Region (2021-2026)
Table 40. APAC Nifedipine Extended Release Tablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Nifedipine Extended Release Tablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC Nifedipine Extended Release Tablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe Nifedipine Extended Release Tablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe Nifedipine Extended Release Tablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Nifedipine Extended Release Tablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe Nifedipine Extended Release Tablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Nifedipine Extended Release Tablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Nifedipine Extended Release Tablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Nifedipine Extended Release Tablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Nifedipine Extended Release Tablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Nifedipine Extended Release Tablets
Table 52. Key Market Challenges & Risks of Nifedipine Extended Release Tablets
Table 53. Key Industry Trends of Nifedipine Extended Release Tablets
Table 54. Nifedipine Extended Release Tablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Nifedipine Extended Release Tablets Distributors List
Table 57. Nifedipine Extended Release Tablets Customer List
Table 58. Global Nifedipine Extended Release Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Nifedipine Extended Release Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Nifedipine Extended Release Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Nifedipine Extended Release Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Nifedipine Extended Release Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Nifedipine Extended Release Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Nifedipine Extended Release Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Nifedipine Extended Release Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Nifedipine Extended Release Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Nifedipine Extended Release Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Nifedipine Extended Release Tablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Nifedipine Extended Release Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Nifedipine Extended Release Tablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Nifedipine Extended Release Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Valeant Pharmaceuticals Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 74. Valeant Pharmaceuticals Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Valeant Pharmaceuticals Main Business
Table 76. Valeant Pharmaceuticals Latest Developments
Table 77. Zydus Pharmaceuticals Inc Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 79. Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Zydus Pharmaceuticals Inc Main Business
Table 81. Zydus Pharmaceuticals Inc Latest Developments
Table 82. Aurobindo Pharma LTD Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 84. Aurobindo Pharma LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Aurobindo Pharma LTD Main Business
Table 86. Aurobindo Pharma LTD Latest Developments
Table 87. Pfizer Inc Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Inc Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 89. Pfizer Inc Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Pfizer Inc Main Business
Table 91. Pfizer Inc Latest Developments
Table 92. Sun Pharma Industries LTD Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 94. Sun Pharma Industries LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sun Pharma Industries LTD Main Business
Table 96. Sun Pharma Industries LTD Latest Developments
Table 97. Osmotica Pharmaceuticals Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 99. Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Osmotica Pharmaceuticals Main Business
Table 101. Osmotica Pharmaceuticals Latest Developments
Table 102. Alkem Laboratories Ltd. Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 104. Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Alkem Laboratories Ltd. Main Business
Table 106. Alkem Laboratories Ltd. Latest Developments
Table 107. Novast Novast Laboratories, LTD Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 109. Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Novast Novast Laboratories, LTD Main Business
Table 111. Novast Novast Laboratories, LTD Latest Developments
Table 112. TWi Pharmaceuticals Inc. Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 113. TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 114. TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. TWi Pharmaceuticals Inc. Main Business
Table 116. TWi Pharmaceuticals Inc. Latest Developments
Table 117. Shyndec Pharmaceutical Co., Ltd Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 119. Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Shyndec Pharmaceutical Co., Ltd Main Business
Table 121. Shyndec Pharmaceutical Co., Ltd Latest Developments
Table 122. China National Pharmaceutical Industry Co., Ltd Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 123. China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 124. China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. China National Pharmaceutical Industry Co., Ltd Main Business
Table 126. China National Pharmaceutical Industry Co., Ltd Latest Developments
Table 127. China Resource Pharmaceutical Group Co., Ltd Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 128. China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 129. China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. China Resource Pharmaceutical Group Co., Ltd Main Business
Table 131. China Resource Pharmaceutical Group Co., Ltd Latest Developments
Table 132. Anglikang Pharmaceutical Co., Ltd Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 133. Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 134. Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Anglikang Pharmaceutical Co., Ltd Main Business
Table 136. Anglikang Pharmaceutical Co., Ltd Latest Developments
Table 137. Warrant Chiral Pharmaceutical Co., Ltd Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 138. Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 139. Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Warrant Chiral Pharmaceutical Co., Ltd Main Business
Table 141. Warrant Chiral Pharmaceutical Co., Ltd Latest Developments
Table 142. Tailison Pharmaceutical Co., Ltd Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 143. Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 144. Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Tailison Pharmaceutical Co., Ltd Main Business
Table 146. Tailison Pharmaceutical Co., Ltd Latest Developments
Table 147. Baheal Medical Inc. Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 148. Baheal Medical Inc. Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 149. Baheal Medical Inc. Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Baheal Medical Inc. Main Business
Table 151. Baheal Medical Inc. Latest Developments
Table 152. Bocheng Pharmaceutical Co., Ltd Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 153. Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 154. Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Bocheng Pharmaceutical Co., Ltd Main Business
Table 156. Bocheng Pharmaceutical Co., Ltd Latest Developments
Table 1. Nifedipine Extended Release Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nifedipine Extended Release Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. Global Nifedipine Extended Release Tablets Sales by Type (2021-2026) & (K Units)
Table 6. Global Nifedipine Extended Release Tablets Sales Market Share by Type (2021-2026)
Table 7. Global Nifedipine Extended Release Tablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Nifedipine Extended Release Tablets Revenue Market Share by Type (2021-2026)
Table 9. Global Nifedipine Extended Release Tablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Nifedipine Extended Release Tablets Sale by Application (2021-2026) & (K Units)
Table 11. Global Nifedipine Extended Release Tablets Sale Market Share by Application (2021-2026)
Table 12. Global Nifedipine Extended Release Tablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global Nifedipine Extended Release Tablets Revenue Market Share by Application (2021-2026)
Table 14. Global Nifedipine Extended Release Tablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Nifedipine Extended Release Tablets Sales by Company (2021-2026) & (K Units)
Table 16. Global Nifedipine Extended Release Tablets Sales Market Share by Company (2021-2026)
Table 17. Global Nifedipine Extended Release Tablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Nifedipine Extended Release Tablets Revenue Market Share by Company (2021-2026)
Table 19. Global Nifedipine Extended Release Tablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Nifedipine Extended Release Tablets Producing Area Distribution and Sales Area
Table 21. Players Nifedipine Extended Release Tablets Products Offered
Table 22. Nifedipine Extended Release Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Nifedipine Extended Release Tablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Nifedipine Extended Release Tablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global Nifedipine Extended Release Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Nifedipine Extended Release Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Nifedipine Extended Release Tablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Nifedipine Extended Release Tablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global Nifedipine Extended Release Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Nifedipine Extended Release Tablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Nifedipine Extended Release Tablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas Nifedipine Extended Release Tablets Sales Market Share by Country (2021-2026)
Table 35. Americas Nifedipine Extended Release Tablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Nifedipine Extended Release Tablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas Nifedipine Extended Release Tablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC Nifedipine Extended Release Tablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC Nifedipine Extended Release Tablets Sales Market Share by Region (2021-2026)
Table 40. APAC Nifedipine Extended Release Tablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Nifedipine Extended Release Tablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC Nifedipine Extended Release Tablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe Nifedipine Extended Release Tablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe Nifedipine Extended Release Tablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Nifedipine Extended Release Tablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe Nifedipine Extended Release Tablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Nifedipine Extended Release Tablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Nifedipine Extended Release Tablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Nifedipine Extended Release Tablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Nifedipine Extended Release Tablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Nifedipine Extended Release Tablets
Table 52. Key Market Challenges & Risks of Nifedipine Extended Release Tablets
Table 53. Key Industry Trends of Nifedipine Extended Release Tablets
Table 54. Nifedipine Extended Release Tablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Nifedipine Extended Release Tablets Distributors List
Table 57. Nifedipine Extended Release Tablets Customer List
Table 58. Global Nifedipine Extended Release Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Nifedipine Extended Release Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Nifedipine Extended Release Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Nifedipine Extended Release Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Nifedipine Extended Release Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Nifedipine Extended Release Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Nifedipine Extended Release Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Nifedipine Extended Release Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Nifedipine Extended Release Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Nifedipine Extended Release Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Nifedipine Extended Release Tablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Nifedipine Extended Release Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Nifedipine Extended Release Tablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Nifedipine Extended Release Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Valeant Pharmaceuticals Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Valeant Pharmaceuticals Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 74. Valeant Pharmaceuticals Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Valeant Pharmaceuticals Main Business
Table 76. Valeant Pharmaceuticals Latest Developments
Table 77. Zydus Pharmaceuticals Inc Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 79. Zydus Pharmaceuticals Inc Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Zydus Pharmaceuticals Inc Main Business
Table 81. Zydus Pharmaceuticals Inc Latest Developments
Table 82. Aurobindo Pharma LTD Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Aurobindo Pharma LTD Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 84. Aurobindo Pharma LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Aurobindo Pharma LTD Main Business
Table 86. Aurobindo Pharma LTD Latest Developments
Table 87. Pfizer Inc Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Inc Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 89. Pfizer Inc Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Pfizer Inc Main Business
Table 91. Pfizer Inc Latest Developments
Table 92. Sun Pharma Industries LTD Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Sun Pharma Industries LTD Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 94. Sun Pharma Industries LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sun Pharma Industries LTD Main Business
Table 96. Sun Pharma Industries LTD Latest Developments
Table 97. Osmotica Pharmaceuticals Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 99. Osmotica Pharmaceuticals Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Osmotica Pharmaceuticals Main Business
Table 101. Osmotica Pharmaceuticals Latest Developments
Table 102. Alkem Laboratories Ltd. Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 104. Alkem Laboratories Ltd. Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Alkem Laboratories Ltd. Main Business
Table 106. Alkem Laboratories Ltd. Latest Developments
Table 107. Novast Novast Laboratories, LTD Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 109. Novast Novast Laboratories, LTD Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Novast Novast Laboratories, LTD Main Business
Table 111. Novast Novast Laboratories, LTD Latest Developments
Table 112. TWi Pharmaceuticals Inc. Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 113. TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 114. TWi Pharmaceuticals Inc. Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. TWi Pharmaceuticals Inc. Main Business
Table 116. TWi Pharmaceuticals Inc. Latest Developments
Table 117. Shyndec Pharmaceutical Co., Ltd Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 119. Shyndec Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Shyndec Pharmaceutical Co., Ltd Main Business
Table 121. Shyndec Pharmaceutical Co., Ltd Latest Developments
Table 122. China National Pharmaceutical Industry Co., Ltd Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 123. China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 124. China National Pharmaceutical Industry Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. China National Pharmaceutical Industry Co., Ltd Main Business
Table 126. China National Pharmaceutical Industry Co., Ltd Latest Developments
Table 127. China Resource Pharmaceutical Group Co., Ltd Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 128. China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 129. China Resource Pharmaceutical Group Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. China Resource Pharmaceutical Group Co., Ltd Main Business
Table 131. China Resource Pharmaceutical Group Co., Ltd Latest Developments
Table 132. Anglikang Pharmaceutical Co., Ltd Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 133. Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 134. Anglikang Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Anglikang Pharmaceutical Co., Ltd Main Business
Table 136. Anglikang Pharmaceutical Co., Ltd Latest Developments
Table 137. Warrant Chiral Pharmaceutical Co., Ltd Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 138. Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 139. Warrant Chiral Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Warrant Chiral Pharmaceutical Co., Ltd Main Business
Table 141. Warrant Chiral Pharmaceutical Co., Ltd Latest Developments
Table 142. Tailison Pharmaceutical Co., Ltd Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 143. Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 144. Tailison Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Tailison Pharmaceutical Co., Ltd Main Business
Table 146. Tailison Pharmaceutical Co., Ltd Latest Developments
Table 147. Baheal Medical Inc. Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 148. Baheal Medical Inc. Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 149. Baheal Medical Inc. Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Baheal Medical Inc. Main Business
Table 151. Baheal Medical Inc. Latest Developments
Table 152. Bocheng Pharmaceutical Co., Ltd Basic Information, Nifedipine Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 153. Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Product Portfolios and Specifications
Table 154. Bocheng Pharmaceutical Co., Ltd Nifedipine Extended Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Bocheng Pharmaceutical Co., Ltd Main Business
Table 156. Bocheng Pharmaceutical Co., Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nifedipine Extended Release Tablets
Figure 2. Nifedipine Extended Release Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nifedipine Extended Release Tablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Nifedipine Extended Release Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nifedipine Extended Release Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nifedipine Extended Release Tablets Sales Market Share by Country/Region (2025)
Figure 10. Nifedipine Extended Release Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Original Drug
Figure 12. Product Picture of Generic Drug
Figure 13. Global Nifedipine Extended Release Tablets Sales Market Share by Type in 2026
Figure 14. Global Nifedipine Extended Release Tablets Revenue Market Share by Type (2021-2026)
Figure 15. Nifedipine Extended Release Tablets Consumed in Hospital
Figure 16. Global Nifedipine Extended Release Tablets Market: Hospital (2021-2026) & (K Units)
Figure 17. Nifedipine Extended Release Tablets Consumed in Pharmacy
Figure 18. Global Nifedipine Extended Release Tablets Market: Pharmacy (2021-2026) & (K Units)
Figure 19. Nifedipine Extended Release Tablets Consumed in Others
Figure 20. Global Nifedipine Extended Release Tablets Market: Others (2021-2026) & (K Units)
Figure 21. Global Nifedipine Extended Release Tablets Sale Market Share by Application (2025)
Figure 22. Global Nifedipine Extended Release Tablets Revenue Market Share by Application in 2026
Figure 23. Nifedipine Extended Release Tablets Sales by Company in 2026 (K Units)
Figure 24. Global Nifedipine Extended Release Tablets Sales Market Share by Company in 2026
Figure 25. Nifedipine Extended Release Tablets Revenue by Company in 2026 ($ millions)
Figure 26. Global Nifedipine Extended Release Tablets Revenue Market Share by Company in 2026
Figure 27. Global Nifedipine Extended Release Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Nifedipine Extended Release Tablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Nifedipine Extended Release Tablets Sales 2021-2026 (K Units)
Figure 30. Americas Nifedipine Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 31. APAC Nifedipine Extended Release Tablets Sales 2021-2026 (K Units)
Figure 32. APAC Nifedipine Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 33. Europe Nifedipine Extended Release Tablets Sales 2021-2026 (K Units)
Figure 34. Europe Nifedipine Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Nifedipine Extended Release Tablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Nifedipine Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 37. Americas Nifedipine Extended Release Tablets Sales Market Share by Country in 2026
Figure 38. Americas Nifedipine Extended Release Tablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas Nifedipine Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 40. Americas Nifedipine Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 41. United States Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Nifedipine Extended Release Tablets Sales Market Share by Region in 2026
Figure 46. APAC Nifedipine Extended Release Tablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC Nifedipine Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 48. APAC Nifedipine Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 49. China Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Nifedipine Extended Release Tablets Sales Market Share by Country in 2026
Figure 57. Europe Nifedipine Extended Release Tablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe Nifedipine Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 59. Europe Nifedipine Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 60. Germany Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Nifedipine Extended Release Tablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Nifedipine Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Nifedipine Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Nifedipine Extended Release Tablets in 2026
Figure 74. Manufacturing Process Analysis of Nifedipine Extended Release Tablets
Figure 75. Industry Chain Structure of Nifedipine Extended Release Tablets
Figure 76. Channels of Distribution
Figure 77. Global Nifedipine Extended Release Tablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global Nifedipine Extended Release Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Nifedipine Extended Release Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Nifedipine Extended Release Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Nifedipine Extended Release Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Nifedipine Extended Release Tablets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Nifedipine Extended Release Tablets
Figure 2. Nifedipine Extended Release Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nifedipine Extended Release Tablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Nifedipine Extended Release Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nifedipine Extended Release Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nifedipine Extended Release Tablets Sales Market Share by Country/Region (2025)
Figure 10. Nifedipine Extended Release Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Original Drug
Figure 12. Product Picture of Generic Drug
Figure 13. Global Nifedipine Extended Release Tablets Sales Market Share by Type in 2026
Figure 14. Global Nifedipine Extended Release Tablets Revenue Market Share by Type (2021-2026)
Figure 15. Nifedipine Extended Release Tablets Consumed in Hospital
Figure 16. Global Nifedipine Extended Release Tablets Market: Hospital (2021-2026) & (K Units)
Figure 17. Nifedipine Extended Release Tablets Consumed in Pharmacy
Figure 18. Global Nifedipine Extended Release Tablets Market: Pharmacy (2021-2026) & (K Units)
Figure 19. Nifedipine Extended Release Tablets Consumed in Others
Figure 20. Global Nifedipine Extended Release Tablets Market: Others (2021-2026) & (K Units)
Figure 21. Global Nifedipine Extended Release Tablets Sale Market Share by Application (2025)
Figure 22. Global Nifedipine Extended Release Tablets Revenue Market Share by Application in 2026
Figure 23. Nifedipine Extended Release Tablets Sales by Company in 2026 (K Units)
Figure 24. Global Nifedipine Extended Release Tablets Sales Market Share by Company in 2026
Figure 25. Nifedipine Extended Release Tablets Revenue by Company in 2026 ($ millions)
Figure 26. Global Nifedipine Extended Release Tablets Revenue Market Share by Company in 2026
Figure 27. Global Nifedipine Extended Release Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Nifedipine Extended Release Tablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Nifedipine Extended Release Tablets Sales 2021-2026 (K Units)
Figure 30. Americas Nifedipine Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 31. APAC Nifedipine Extended Release Tablets Sales 2021-2026 (K Units)
Figure 32. APAC Nifedipine Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 33. Europe Nifedipine Extended Release Tablets Sales 2021-2026 (K Units)
Figure 34. Europe Nifedipine Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Nifedipine Extended Release Tablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Nifedipine Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 37. Americas Nifedipine Extended Release Tablets Sales Market Share by Country in 2026
Figure 38. Americas Nifedipine Extended Release Tablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas Nifedipine Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 40. Americas Nifedipine Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 41. United States Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Nifedipine Extended Release Tablets Sales Market Share by Region in 2026
Figure 46. APAC Nifedipine Extended Release Tablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC Nifedipine Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 48. APAC Nifedipine Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 49. China Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Nifedipine Extended Release Tablets Sales Market Share by Country in 2026
Figure 57. Europe Nifedipine Extended Release Tablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe Nifedipine Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 59. Europe Nifedipine Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 60. Germany Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Nifedipine Extended Release Tablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Nifedipine Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Nifedipine Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Nifedipine Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Nifedipine Extended Release Tablets in 2026
Figure 74. Manufacturing Process Analysis of Nifedipine Extended Release Tablets
Figure 75. Industry Chain Structure of Nifedipine Extended Release Tablets
Figure 76. Channels of Distribution
Figure 77. Global Nifedipine Extended Release Tablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global Nifedipine Extended Release Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Nifedipine Extended Release Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Nifedipine Extended Release Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Nifedipine Extended Release Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Nifedipine Extended Release Tablets Revenue Market Share Forecast by Application (2027-2032)
